"Eli Lilly is in talks to acquire AtaiBeckley, one of the leading developers of next-generation psychedelic therapies."
ZeroHedge Reads
Alt-Market
AntiWar.com
Bitcoin Magazine
Bombthrower
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly agrees to $3.8B psychedelic buy
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet
Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckley
Psychedelic drugs are going mainstream
